Growing community of inventors

North Andover, MA, United States of America

Joseph G Reynolds

Average Co-Inventor Count = 6.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Joseph G ReynoldsThomas Joseph Wickham (3 patents)Joseph G ReynoldsBart S Hendriks (3 patents)Joseph G ReynoldsElena Geretti (3 patents)Joseph G ReynoldsKenneth J Olivier, Jr (2 patents)Joseph G ReynoldsStephan Klinz (2 patents)Joseph G ReynoldsVictor Mandla Moyo (1 patent)Joseph G ReynoldsChristopher W Espelin (1 patent)Joseph G ReynoldsJoseph G Reynolds (3 patents)Thomas Joseph WickhamThomas Joseph Wickham (15 patents)Bart S HendriksBart S Hendriks (7 patents)Elena GerettiElena Geretti (3 patents)Kenneth J Olivier, JrKenneth J Olivier, Jr (2 patents)Stephan KlinzStephan Klinz (2 patents)Victor Mandla MoyoVictor Mandla Moyo (43 patents)Christopher W EspelinChristopher W Espelin (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merrimack Pharmaceuticals, Inc. (3 from 52 patents)


3 patents:

1. 9913901 - Combination therapy for treating HER2-positive cancers

2. 9610249 - Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents

3. 9226966 - Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…